News
Category
-
PR Newswire
Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
January 4, 2021 -
PR Newswire
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma
December 27, 2020 -
GlobeNewswire
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
December 21, 2020 -
PR Newswire
FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval
December 17, 2020 -
Business Wire
Kyruus and HealthSparq Come Together to Transform Care Navigation Through Novel Payer-Provider Collaboration
December 17, 2020 -
Endpoints News
GlaxoSmithKline plumbs the discovery field (again), betting up to $815M for the latest add-on to its oncology pipeline
December 17, 2020 -
PR Newswire
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
December 17, 2020 -
Business Wire
NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020 -
Crunchbase
Mozper Banks $3.55M To Develop Debit Card, App For LatAm Children
December 14, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
December 10, 2020 -
GlobeNewswire
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
December 9, 2020 -
PR Newswire
Vestwell Partners with Envestnet to Offer Turnkey Retirement Plan Solutions to Industry Advisors
December 9, 2020 -
GlobeNewswire
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
December 8, 2020 -
GlobeNewswire
Flywire Reports Record Growth for Digital Healthcare Payments Platform
December 8, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
December 8, 2020 -
Crunchbase
Centivo Secures $34M Series B To Scale Self-funded Employer Health Plan
December 7, 2020 -
PR Newswire
Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
December 7, 2020 -
GlobeNewswire
Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
December 4, 2020 -
GlobeNewswire
Adagene Announces Expansion of Leadership Team to Support Strategic Growth
December 2, 2020 -
Business Wire
ConnexPay Raises Additional Funding to Propel Adoption of Payments Technology
December 1, 2020 -
Business Wire
Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating RIVAL-01 For the Treatment of Solid Tumors
December 1, 2020 -
PR Newswire
OTA Insight Announces Atomize is First RMS to Ingest Company’s Revolutionary New Forward-Looking Data Sets
December 1, 2020 -
PR Newswire
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
December 1, 2020 -
PR Newswire
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
November 22, 2020 -
FierceBiotech
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
November 20, 2020 -
GlobeNewswire
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
November 19, 2020 -
PR Newswire
Toast Leadership Team Named Entrepreneur Of The Year® 2020 National Overall Award Winner
November 19, 2020 -
Business Wire
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
November 18, 2020 -
GlobeNewswire
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH
November 16, 2020 -
PR Newswire
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
November 15, 2020 -
GlobeNewswire
Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
November 13, 2020 -
GlobeNewswire
Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia at AASLD
November 13, 2020 -
Business Wire
Xilio Therapeutics Presents Promising Preclinical Tumor-Selective Efficacy and Safety Data for XTX201 (IL-2) and XTX101 (anti-CTLA-4) at SITC
November 12, 2020 -
PR Newswire
Whatfix To Host Second Virtual Digital Adoption Conference
November 10, 2020 -
Business Wire
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 10, 2020 -
PR Newswire
PatientPing Partners with MedAllies to Ensure Hospital Partners’ Compliance with CMS E-Notifications Condition of Participation
November 10, 2020 -
GlobeNewswire
Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (TV) Technology Achieved in Phase 1/2 Study of ETV:IDS (DNL310) in Hunter Syndrome (MPS II)
November 10, 2020 -
PR Newswire
Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
November 10, 2020 -
GlobeNewswire
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
November 9, 2020 -
PR Newswire
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
November 9, 2020 -
GlobeNewswire
Beam Therapeutics Names First CAR-T Base Editing Development Candidate for the Treatment of T-ALL and Presents New Data at SITC 2020
November 9, 2020 -
GlobeNewswire
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
November 5, 2020 -
GlobeNewswire
Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020
November 4, 2020 -
PR Newswire
Sana Biotechnology Announces Acquisition of Oscine
October 30, 2020 -
Endpoints News
Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem
October 28, 2020 -
Crunchbase
French Scale-up Odaseva Raises $25M To Continue Global Expansion
October 27, 2020 -
Business Wire
Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience
October 27, 2020 -
PR Newswire
Apricus Health Partners with Medicare Advantage Plan Devoted Health and Full-Service Retail Pharmacy Liton Rx
October 27, 2020 -
PR Newswire
Arcadia Expands Partnership with PatientPing, Enhancing Access to Real-Time Patient Data for Healthcare Organizations
October 27, 2020 -
The Irish Sun
Irish device that kills 99.999 per cent of Covid in air ‘could help end lockdown’ and get businesses open
October 26, 2020 -
GlobeNewswire
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
October 23, 2020 -
GlobeNewswire
Orchard Therapeutics CEO Bobby Gaspar, M.D., Ph.D., Appointed to the Alliance for Regenerative Medicine’s 2021 Board of Directors
October 22, 2020 -
FierceBiotech
Compass aims at $50M IPO to push lead antibody through the clinic
October 20, 2020 -
PR Newswire
TraceLink Announces New Serialized Product Intelligence Solution
October 20, 2020 -
PR Newswire
PatientPing Commends Its Community of MSSP Accountable Care Organizations for Generating Over $517 Million in Shared Savings – a 20% Improvement Over Last Year
October 20, 2020 -
PR Web
Devoted Health Launches Compassionate, Affordable Medicare Advantage Plans in Arizona
October 20, 2020 -
Business Wire
Wellframe Partners with ZeOmega to Help Health Plans Offer an Enhanced Digital Experience
October 19, 2020 -
GlobeNewswire
Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
October 16, 2020 -
GlobeNewswire
Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
October 15, 2020 -
PR Newswire
Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery
October 15, 2020 -
ACN News
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
October 13, 2020 -
TechCrunch
Snapdocs raises $60M to manage the mortgage process in the cloud
October 12, 2020 -
PR Newswire
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China
October 9, 2020 -
GlobeNewswire
Denali Therapeutics Announces Closing of Collaboration and Share Purchase Agreements with Biogen
October 7, 2020 -
GlobeNewswire
Flywire Announces Partnership with Brazilian Educational & Language Travel Association (BELTA)
October 7, 2020 -
Business Wire
Caribou Biosciences Co-Founder Dr. Jennifer Doudna Awarded Nobel Prize in Chemistry
October 7, 2020 -
GlobeNewswire
Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US
October 6, 2020 -
GlobeNewswire
ProcessUnity and RiskRecon Partner to Provide Customers Access to Data-Driven Third-Party Security Ratings
October 6, 2020 -
PR Newswire
Applied BioMath, LLC Announces Two-Year Strategic Partnership with Xilio Therapeutics
October 5, 2020 -
PR Newswire
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
October 5, 2020 -
PR Newswire
TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement
September 30, 2020 -
Business Wire
Xilio Therapeutics Appoints Rachel Humphrey, M.D. to Board of Directors
September 29, 2020 -
GlobeNewswire
Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I
September 28, 2020 -
GlobeNewswire
Beam Therapeutics Announces Proposed Public Offering of Common Stock
September 28, 2020 -
PR Newswire
Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
September 25, 2020 -
BioPharma Journal
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma
September 25, 2020 -
PR Newswire
Benchling Appoints Biotech and SaaS Veterans to Board of Directors
September 23, 2020 -
GlobeNewswire
Flywire Announces Foundation Scholarship Winners for Fall 2020
September 23, 2020 -
PR Newswire
Whatfix for ISVs is Now Available, Helping Partners and Customers Accelerate Technology Adoption and Digital Transformation
September 22, 2020 -
PR Newswire
Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Patients with Advanced Systemic Mastocytosis
September 22, 2020 -
GlobeNewswire
Getaround Selects Snapsheet’s End-to-End Digital Claims Management Platform
September 22, 2020 -
GlobeNewswire
Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
September 21, 2020 -
PR Newswire
Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
September 21, 2020 -
PR Newswire
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
September 21, 2020 -
PR Newswire
Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO™ (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer
September 20, 2020 -
PR Newswire
Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resistant EGFR-Mutated Lung Cancer at ESMO Virtual Congress 2020
September 17, 2020 -
GlobeNewswire
Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
September 17, 2020 -
GlobeNewswire
Flywire and Mastercard Team Up to Simplify Cross-Border Tuition Payments
September 17, 2020 -
GlobeNewswire
NTU Singapore and Flywire partner to offer new digital payment platform for international students
September 16, 2020 -
Business Wire
Wellframe’s Melissa Herman Named 2020 CFO of the Year by Boston Business Journal
September 15, 2020